Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00971087 · ClinicalTrials.gov registry record · NA

Multicenter Hologic Tomosynthesis Study

A NA study, sponsored by Hologic.

Completed
Registry status
NA
Development phase
3,521
Enrollment target

NCT00971087 is a NA study that has completed, run by Hologic. The registered enrollment target is 3,521 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00971087, a NA study, has completed, sponsored by Hologic.

COMPLETED
Registry status
NA
Development phase
3,521 participants
Enrollment target

Study Summary

The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an over view of the anatomy similar to a scout view in CT imaging and to determine whether the 3-D images with the synthesized 2D overview are non-inferior to the 2-D images alone as determined by receiver operating characteristic (ROC) area under the curve.

Interventions

  • DEVICE Hologic Selenia Dimensions Digital Breast Tomosynthesis System

Trial Details

FieldValue
Enrollment Target 3,521 participants
Start Date 2009-09
Est. Completion 2012-04
Phase NA

Sponsor

Hologic

21 total trials

What the Registry Record Tells You About NCT00971087

The ClinicalTrials.gov registry entry for NCT00971087 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,521 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Hologic Selenia Dimensions Digital Breast Tomosynthesis System is the first listed.

NCT00971087 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00971087 about?

NCT00971087 is a clinical study titled "Multicenter Hologic Tomosynthesis Study". The purpose of this image acquisition study is to compare, in a Reader Study, the performance of Tomosynthesis (3D) to (2D FFDM) conventional images in an enriched retrospective reader study. Synthetic 2D images, generated from the tomosynthesis image, will be available to the readers to provide an ...

What is the current status of trial NCT00971087?

This trial is currently completed. It is a NA study. The enrollment target is 3,521 participants. The study started on 2009-09. Estimated completion is 2012-04.

What interventions are being tested in trial NCT00971087?

The interventions under investigation include: Hologic Selenia Dimensions Digital Breast Tomosynthesis System (DEVICE).

Who is sponsoring clinical trial NCT00971087?

This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.